openPR Logo
Press release

Facing the challenge of efficiency in bio-pharmaceutical industry

12-28-2009 11:29 AM CET | Science & Education

Press release from: YMC Europe GmbH

YMC BioPro QA

YMC BioPro QA

With continuously increasing volumetric productivity in fermentation processes, new stationary phases can help to overcome shortcomings in downstream processing. In order to address this YMC has developed a new Ion Exchange resin with high dynamic binding capacity and low nonspecific interaction. This helps to reduce “cost of goods” in the production process.

The Ion Exchange capture material is based on the same hydrophilic polymer matrix already used for the successful analytical phase.

Analytical BioPro columns (particle size: 5µm, pore size 100 nm) have proven to show low non specific binding and high dynamic binding capacity. Results from the continuously growing user-base confirm: the new

BioPro is a high class IEX phase.

As can be seen in the figure the analytical phase already shows excellent loadability. Now, a capture material with similar properties is available. The material is offered with a particle size of 75µm and a pore size of 100 nm. The narrow particle size distribution makes it perfect for high capacity capture steps with low backpressure and highly efficient intermediate purification steps. (More particle sizes are in preparation.)

From headquarters located in Kyoto, Japan, YMC has gradually and consistently matured to a level of international recognition, specifically within the pharmaceutical and biotech world, as one of the leading suppliers of analytical and process-scale silica-based stationary phases for High Performance Liquid Chromatography, preparative equipment, custom purification and method development.
New: Micro Reactor / Flow Chemistry scalable to production scale!
Qualified technical support and backup is available through operations in Japan, the United States (for the "Americas"), India, China and Germany (for Europe, Africa and the Middle East). www.ymc.de

YMC Europe GmbH
Daniel Kune
Schöttmannshof 19
46539 Dinslaken
Germany

Te.: +49 (0)2064-427 270
E-Mail: kune@ymc.de
www.ymc.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Facing the challenge of efficiency in bio-pharmaceutical industry here

News-ID: 113446 • Views:

More Releases from YMC Europe GmbH

Versatile (U)HPLC-hybrid columns, now also in C8!
Versatile (U)HPLC-hybrid columns, now also in C8!
With YMC-TriArt challenging pH-stability and high temperatures are no longer a limitation to your work. Above all due to its unique particle composition a balanced hydrophibicty and silanol activity are achieved which makes YMC-TriArt a “First Choice” column in method development! This new, innovative stationary phase YMC-TriArt fulfils all the requirements for modern, highly demanding chromatographic separations: - Versatility: balanced hydrophobicity and silanol activity. - Flexibility:
IEX columns for material screening and method development
IEX columns for material screening and method development
Are you sure your column has been packed the best possible way? Until now the extremely efficient YMC-BioPro IEX phases have only been available as bulk media. Still it was introduced into many screening procedures in industry, because of its high quality. Now it is even easier to evaluate its extremely good cost-efficiency ratio: YMC announces the introduction of pre-packed IEX columns. The columns are always perfectly packed and, after equilibration
The YMC HG-series: High Quality low price silica material
The YMC HG-series: High Quality low price silica material
Is it possible to get the best of both worlds? Better quality at better price? It is possible with the new YMC HG-grade series of silica based materials! These new phases combine the trusted selectivity of the YMC*gel materials with a new high performance silica base. The most obvious advantage of the new silica base is its extended mechanical stability which is due to an improved production process for the base
Easy handling with Kronlab Pilot columns
Easy handling with Kronlab Pilot columns
Advanced service and cleaning for Kronlab glass Pilot columns As a long-time specialist in the field of glass Pilot columns for lab and production separations, Kronlab specialists are continuously in close dialogue with chromatography end-users from Pharma/Biotech as well as research and education fields. This leads to numerous technical and practical modifications which make your every-day work a lot easier. The latest innovations are the stands of the Kronlab glass Pilot columns.

All 5 Releases


More Releases for BioPro

Biologic Imaging Reagents Market 2020 Analysis: Leading Players are Promega Corp …
This report provides research study on “Global Biologic Imaging Reagents Market”. It offers the comparative assessment of Biologic Imaging Reagents Market and consists of historical data, significance, statistical data, size & share, market Price & demand, business overview, market analysis by product and market trends by key players. The Global Biologic Imaging Reagents Market report comprehensively studies market definition, market segmentation, competitive analysis and key developments in the market. It comprises of fundamental, secondary and
Hammertoe Market Comprehensive Analysis On BioPro, Instratek, Stryker, Extremity …
Global Hammertoe Market Type (Flexible Hammer Toes, Rigid Hammer Toes), Diagnosis (Physical Exam, X-Rays, Others), Treatment (Drugs, Orthotic Devices, Surgery, Others), End Users (Hospitals, Clinics, Physiotherapy & Orthopedic Centers), Geography- Industry Trends and Forecast to 2025 Get Sample Copy Of Report For More Information@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-hammertoe-market Hammertoe Market Report covers the comprehensive market, vendor landscape, present scenario, and the growth prospects of the Hammertoe for 2018-2025. Report, consists of various factors such
Hammertoe Market Foremost Players - BioPro, Instratek, Stryker Corporation, Extr …
Market Research Future (MRFR)’s study Reveals that the “Global Hammertoe Market”, the report offer detailed Analysis about the Top Trends and Current Scenario with competitive landscape and key regions development status. Hammertoe Market - Overview A hammertoe is a foot deformity of the second, third or fourth finger in the toe. People with hammertoe may develop corns or calluses on the tip or middle joint of the toe. This condition can cause
Global Hip Resurfacing Implants Market to 2025| Zimmer Biomet Holdings, Smith & …
Albany, NY, 6th September : Recent research and the current scenario as well as future market potential of "Global Market Study on Hip Resurfacing Implants: Tin Coated Segment by Material Type Anticipated to Showcase Lowest Market Valuation By 2025 End" globally. The comprehensive research report titled “Hip Resurfacing Implants Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)” by Persistence Market Research assists the reader in chalking key growth strategies on the
Hammertoe Market 2018 Topmost Players | BioPro, Instratek, Stryker, Wright Medic …
The Global Hammertoe Market is expected to reach US$ 450 million by 2023, and the market is projected to grow at a CAGR of ~ 5.2 % during the forecast period 2017-2023. Hammertoe is a foot deformity due to imbalance in the muscles, tendons or ligaments which normally hold the toe straight. A hammertoe has an abnormal bend in the middle joint of a toe and usually occur in the second,
Hammertoe Market 2017: Key Players – BioPro, Instratek, Stryker, Extremity Med …
The Worldwide Hammertoe Market inquire about report is developing with the quick pace; chiefly due the prospering Healthcare Sector. As per a current report distributed by the Market Research Future, The World Hammertoe Industry Research report is blasting and anticipated that would pick up unmistakable quality over the conjecture time frame. The Market is anticipated to exhibit a colossal development by 2023, outperforming its past development records as far as